Microbicide Trials Network

The Use of Mucosal Assays in Microbicide Trials

About the Event
Event Type: 
Event Date(s): 
Tue, 08/25/2015 - 07:30 - Wed, 08/26/2015 - 17:00

This event was held at the Key Bridge Marriot, Arlington, VA, on August 25-26, 2015.  Presentations from this meeting are posted below.

Presentations from August 25, 2015
CAMERON: The CHARM-01 Study: Assessing Formulations of Tenofovir 1% Gel in HIV Seronegative Adults Via Transcriptome Analysis2015-Aug-251.05 MB
DEZZUTTI: Mucosal Assays in HIV Prevention Trials: Vaginal Microbicide Trials2015-Aug-25332.07 KB
DUFFIL: Flow Cytometry Laboratory Considerations2015-Aug-25977.95 KB
HILLIER: Culture Based Techniques in the Omics Era2015-Aug-25824.19 KB
HLADIK: Pioneering systems biology in clinical microbicide trials – MTN-007 and beyond2015-Aug-251.02 MB
MARRAZZO: The Genital Microbiome in Studies of Bacterial Vaginosis2015-Aug-252.29 MB
MCGOWAN: Flow Cytometric Analysis of Gut Biopsies2015-Aug-251.44 MB
MCGOWAN: Mucosal Assays in Oral and Long Acting (LA) Antiretroviral PrEP Trials2015-Aug-25467.54 KB
MCGOWAN: Mucosal Assays in Rectal Microbicide Trials2015-Aug-25904.34 KB
RICHARDSON: Statistical Considerations2015-Aug-25100.41 KB
Presentations from August 26, 2015
BUMPUS: Discovery of Genetic Variants of the Kinases that Activate Tenofovir in a Compartment-Specific Manner2015-Aug-26500.39 KB
DEZZUTTI: Pharmacodynamics: Genital Tract Pharmacodynamics2015-Aug-26950.87 KB
HENDRIX: Pharmacokinetics in Microbicide Development2015-Aug-261.52 MB
MCGOWAN: Rectal Compartment Pharmacodynamics2015-Aug-261.23 MB
RICHARDSON-HARMAN: Integrating PK/PD2015-Aug-26413.82 KB